Literature DB >> 23208094

Aptamer microarray as a novel bioassay for protein-protein interaction discovery and analysis.

Lin-Chi Chen1, Shin-Cheng Tzeng, Konan Peck.   

Abstract

Aptamer microarray is investigated as a novel bioassay for protein-protein interaction (PPI) discovery and analysis. Assaying a mixture of fluorescence-labeled thrombin and Escherichia coli proteins with an aptamer microarray, we found that thrombin and an unknown protein of E. coli (protein X) formed a complex of PPI, which was captured by an anti-thrombin aptamer probe. The PPI observed on the microarray was double-checked by protein microarrays and confirmed by aptamer-baited co-immunoprecipitation (Co-IP) assays. Characterizing the Co-IP products, we identified protein X as an E. coli Dps protein (DNA-binding protein from starved cells). A SDS-PAGE analysis suggested that Dps should be a substrate for thrombin, a trypsin-like serine protease. A dose-response microarray experiment predicted an apparent dissociation constant of 1.33 μM for the PPI. Moreover, an on-microarray competition assay revealed that the capture of the PPI by the anti-thrombin aptamer probe would be blocked by an E. coli aptamer via complementary base pairing. Thus, a network of protein-protein, protein-DNA, and DNA-DNA interactions and their interaction orders could be addressed in addition to simple PPI discovery.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23208094     DOI: 10.1016/j.bios.2012.10.082

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  3 in total

Review 1.  Aptamer Microarrays-Current Status and Future Prospects.

Authors:  Martin Witt; Johanna-Gabriela Walter; Frank Stahl
Journal:  Microarrays (Basel)       Date:  2015-03-24

Review 2.  Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease.

Authors:  Rekha Raghunathan; Kathleen Turajane; Li Chin Wong
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

Review 3.  Synthetic biology for pharmaceutical drug discovery.

Authors:  Jean-Yves Trosset; Pablo Carbonell
Journal:  Drug Des Devel Ther       Date:  2015-12-03       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.